Synthesis, Molecular Docking Studies and Biological Evaluation of N-Acylarylhydrazones as Anti-Inflammatory Agents. 2020

Tangirala Sarala Devi, and Galla Rajitha, and Konda Swathi, and Katari Sudheer Kumar, and Amineni Umamaheswari
Department of Pharmaceutical Chemistry, KVSR Siddhartha College of Pharmaceutical Sciences, Vijayawada, Andhra Pradesh, India.

In the present work a series of N'-arylidene-2-(benzamido)-3-(naphthalen-2-yl)acrylohydrazides were synthesized by refluxing the intermediate 2-(benzamido)-3-(naphthalen-2-yl)acrylohydrazide with various substituted benzaldehyde in the presence of glacial acetic acid. The intermediate 2-(benzamido)-3-(naphthalen-2-yl)acrylohydrazide 2 was prepared by stirring 4-((naphthalen-2-yl)methylene)-2-phenyloxazol-5(4H)-one with hydrazine hydrate in the presence of absolute ethanol. The chemical structures of the compounds were established by IR, 1H NMR and mass spectral data. All the compounds were evaluated for anti-inflammatory (in vivo, in vitro) activity and performed docking against COX-2. The compounds 3a, 3c and 3o showed good inhibition of COX-2 in in vitro studies (0.75 μM, 0.5 μM and 0.7 μM as IC50, respectively). The compounds 3c, 3e and 3f were found to be more active than standard drug phenylbutazone at equidose. Molecular docking studies showed that compound 3 m exhibited good binding affinity against COX-2 with docking score 9.328 kcal/mol, when compared to the standard celecoxib.

UI MeSH Term Description Entries
D006835 Hydrazones Compounds of the general formula R:N.NR2, as resulting from the action of hydrazines with aldehydes or ketones. (Grant & Hackh's Chemical Dictionary, 5th ed) Hydrazone
D000893 Anti-Inflammatory Agents Substances that reduce or suppress INFLAMMATION. Anti-Inflammatory Agent,Antiinflammatory Agent,Agents, Anti-Inflammatory,Agents, Antiinflammatory,Anti-Inflammatories,Antiinflammatories,Antiinflammatory Agents,Agent, Anti-Inflammatory,Agent, Antiinflammatory,Agents, Anti Inflammatory,Anti Inflammatories,Anti Inflammatory Agent,Anti Inflammatory Agents
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D015394 Molecular Structure The location of the atoms, groups or ions relative to one another in a molecule, as well as the number, type and location of covalent bonds. Structure, Molecular,Molecular Structures,Structures, Molecular
D051546 Cyclooxygenase 2 An inducibly-expressed subtype of prostaglandin-endoperoxide synthase. It plays an important role in many cellular processes and INFLAMMATION. It is the target of COX2 INHIBITORS. COX-2 Prostaglandin Synthase,Cyclo-Oxygenase II,Cyclooxygenase-2,PGHS-2,PTGS2,Prostaglandin H Synthase-2,COX 2 Prostaglandin Synthase,Cyclo Oxygenase II,Prostaglandin H Synthase 2,Prostaglandin Synthase, COX-2,Synthase, COX-2 Prostaglandin
D052246 Cyclooxygenase 2 Inhibitors A subclass of cyclooxygenase inhibitors with specificity for CYCLOOXYGENASE-2. COX-2 Inhibitor,COX2 Inhibitor,Coxib,Cyclooxygenase 2 Inhibitor,Cyclooxygenase-2 Inhibitor,COX-2 Inhibitors,COX2 Inhibitors,Coxibs,Cyclooxygenase-2 Inhibitors,2 Inhibitor, Cyclooxygenase,COX 2 Inhibitor,COX 2 Inhibitors,Inhibitor, COX-2,Inhibitor, COX2,Inhibitor, Cyclooxygenase 2,Inhibitor, Cyclooxygenase-2,Inhibitors, COX-2,Inhibitors, COX2,Inhibitors, Cyclooxygenase 2,Inhibitors, Cyclooxygenase-2
D062105 Molecular Docking Simulation A computer simulation technique that is used to model the interaction between two molecules. Typically the docking simulation measures the interactions of a small molecule or ligand with a part of a larger molecule such as a protein. Molecular Docking,Molecular Docking Simulations,Molecular Docking Analysis,Analysis, Molecular Docking,Docking Analysis, Molecular,Docking Simulation, Molecular,Docking, Molecular,Molecular Docking Analyses,Molecular Dockings,Simulation, Molecular Docking

Related Publications

Tangirala Sarala Devi, and Galla Rajitha, and Konda Swathi, and Katari Sudheer Kumar, and Amineni Umamaheswari
October 2022, Bioorganic chemistry,
Tangirala Sarala Devi, and Galla Rajitha, and Konda Swathi, and Katari Sudheer Kumar, and Amineni Umamaheswari
September 2016, Acta poloniae pharmaceutica,
Tangirala Sarala Devi, and Galla Rajitha, and Konda Swathi, and Katari Sudheer Kumar, and Amineni Umamaheswari
February 2017, Bioorganic & medicinal chemistry letters,
Tangirala Sarala Devi, and Galla Rajitha, and Konda Swathi, and Katari Sudheer Kumar, and Amineni Umamaheswari
September 2022, Chemistry & biodiversity,
Tangirala Sarala Devi, and Galla Rajitha, and Konda Swathi, and Katari Sudheer Kumar, and Amineni Umamaheswari
May 2024, RSC advances,
Tangirala Sarala Devi, and Galla Rajitha, and Konda Swathi, and Katari Sudheer Kumar, and Amineni Umamaheswari
October 2014, Chemical biology & drug design,
Tangirala Sarala Devi, and Galla Rajitha, and Konda Swathi, and Katari Sudheer Kumar, and Amineni Umamaheswari
February 2024, Archiv der Pharmazie,
Tangirala Sarala Devi, and Galla Rajitha, and Konda Swathi, and Katari Sudheer Kumar, and Amineni Umamaheswari
April 2017, European journal of pharmacology,
Tangirala Sarala Devi, and Galla Rajitha, and Konda Swathi, and Katari Sudheer Kumar, and Amineni Umamaheswari
April 2024, Medicinal chemistry (Shariqah (United Arab Emirates)),
Tangirala Sarala Devi, and Galla Rajitha, and Konda Swathi, and Katari Sudheer Kumar, and Amineni Umamaheswari
March 2011, Bioorganic & medicinal chemistry letters,
Copied contents to your clipboard!